<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>ANNEXON INC</issuerName>
    <cusip>03589W102</cusip>
    <isin>US03589W1027</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Abstain</howVoted>
        <sharesVoted>2750000</sharesVoted>
        <managementRecommendation>NONE</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AXSOME THERAPEUTICS INC</issuerName>
    <cusip>05464T104</cusip>
    <isin>US05464T1043</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>To approve, by non-binding advisory vote, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>40531</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>40531</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>CELLDEX THERAPEUTICS INC NEW</issuerName>
    <cusip>15117B202</cusip>
    <isin>US15117B2025</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company&#8217;s Named Executive Officers as disclosed in this proxy statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>288650</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>288650</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ENDO, INC</issuerName>
    <cusip>29290D117</cusip>
    <isin>US29290D1173</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the frequency of soliciting an advisory say-on-pay vote (say-on-frequency).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243697</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>243697</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>123</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>ENDO, INC</issuerName>
    <cusip>29290D117</cusip>
    <isin>US29290D1173</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243697</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>243697</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>123</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>KEROS THERAPEUTICS INC</issuerName>
    <cusip>492327101</cusip>
    <isin>US4923271013</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers as disclosed in the accompanying Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>183000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>183000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LYFT INC</issuerName>
    <cusip>55087P104</cusip>
    <isin>US55087P1049</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>The approval of, on an advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>1000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>1000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>RELAY THERAPEUTICS INC</issuerName>
    <cusip>75943R102</cusip>
    <isin>US75943R1023</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>To consider and act upon an advisory vote on the compensation of our executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>699000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>699000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>SNOWFLAKE INC</issuerName>
    <cusip>833445109</cusip>
    <isin>US8334451098</isin>
    <meetingDate>07/02/2024</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>10000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TARSUS PHARMACEUTICALS INC</issuerName>
    <cusip>87650L103</cusip>
    <isin>US87650L1035</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178470</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>178470</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TARSUS PHARMACEUTICALS INC</issuerName>
    <cusip>87650L103</cusip>
    <isin>US87650L1035</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178470</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>1 Year</howVoted>
        <sharesVoted>178470</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>TECTONIC THERAPEUTIC INC</issuerName>
    <cusip>878972108</cusip>
    <isin>US8789721086</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Advisory vote on the frequency of stockholder advisory votes on executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>221320</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>221320</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UIPATH INC</issuerName>
    <cusip>90364P105</cusip>
    <isin>US90364P1057</isin>
    <meetingDate>06/26/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the compensation paid to our named executive officers (&quot;say-on-pay vote&quot;).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>8950000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>8950000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>WARRIOR MET COAL INC</issuerName>
    <cusip>93627C101</cusip>
    <isin>US93627C1018</isin>
    <meetingDate>04/23/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31750</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>31750</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>123</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
</proxyVoteTable>
